This episode reviews the rising burden of cutaneous squamous cell carcinoma (cSCC), highlighting key risk factors, variable clinical presentations, and the growing role of molecular profiling tools in improving risk assessment and clinical decision-making.
This episode examines the diagnostic workflow for cutaneous squamous cell carcinoma (cSCC), emphasizing how clinical, pathological, and patient-specific factors inform risk assessment, prognostication, and individualized management strategies.
How dermatologists size up suspected cutaneous SCC—site, size, risk factors, pathology—to rank risk and choose the right treatment.
Dermatologist shortages delay squamous cell cancer detection; learn practical screening and risk cues that help catch aggressive tumors earlier.
How 41-gene profiling and ctDNA refine cutaneous SCC risk after Mohs, guiding radiation, imaging, and tighter follow-up.
How 41-gene profiling and ctDNA reshape cutaneous SCC care, guiding radiation, imaging, and tighter follow-up for hidden high-risk tumors.
